摘要
目的:观察抗纤益心方对扩张型心肌病患者血压的影响。方法:将85例患者随机分为治疗组43例和对照组42例。两组均常规西药治疗,治疗组在对照组治疗基础上加服抗纤益心方汤治疗,每日1剂,共治疗6个月。观察两组患者治疗前后患者血压变化及影响血压药物酒石酸美托洛尔片、依那普利片剂量的变化。结果:抗纤益心方治疗组虽使用了较大剂量的酒石酸美托洛尔片、依那普利片,但较对照组能更好的维持患者的血压(P<0.05)。结论:抗纤益心方能稳定扩张型心肌病患者的血压,为β阻滞剂及血管紧张素转化酶抑制剂的应用提供了依据。
Objective ： To observe the influence of Kangxinyixin formula on blood pressure of the patients with dilated eardiomyopathy （DCM）. Methods ：85 cases were randomly divided into the treatment group （43 cases） treated with the routine western medicine plus Kangxinyixin formula （one dose daily） ,the control group （42 cases） treated with the routine western medicine. A total of 6 months. Observation of two groups of patients before and after treatment of patients with blood pressure changes and affecting blood pressure drug tartaric acid metoprolol tablets, enalapril dose changes. Results ： Kangxinyixin formula treatment group although the use of large dose of metoprolol tartrate tablets and enalapril, but compared to the control group can better maintain patients＇ blood pressure （ P 〈 0.05 ）. Conclusion ： Kangxinyixin foumula can stabilize the blood pressure of patients with dilated cardiomyop- athy, which provides a space for the application of beta blockers and angiotensin converting enzyme inhibitors.
出处
《中医学报》
CAS
2016年第8期1186-1188,共3页
Acta Chinese Medicine
关键词
心肌病
抗纤益心方汤
血压
中医药疗法
中西医结合
dilated cardiomyopathy
Kangxianyixin formula
blood pressure
TCM therapy
integTated Chinese and western medicine
